Sec. 706. Availability of certain preconception and prenatal carrier screening tests under the TRICARE program
172 words·~1 min read·
/bill/117/hr/4350/pcs/section-706A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Section 1079(a) of title 10, United States Code, is amended by adding at the end the following new paragraph: Preconception and prenatal carrier screening tests shall be provided to covered beneficiaries upon the request of the beneficiary, with a limit per beneficiary of one test per condition per lifetime, for the following conditions: Cystic Fibrosis. Spinal Muscular Atrophy. Fragile X Syndrome. Tay-Sachs Disease. Hemoglobinopathies. Conditions linked with Ashkenazi Jewish descent. .
Not later than one year after the date of the enactment of this Act, the Secretary of Defense shall provide to the congressional defense committees a report identifying the number of beneficiaries under the TRICARE program who have received a screening test under section 1079(a)(18) of title 10, United States Code, as added by subsection (a), disaggregated by type of beneficiary and whether the test was provided under the direct care or purchased care component of the TRICARE program.
In this subsection, the term TRICARE program has the meaning given such term in section 1072 of title 10, United States Code.